Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
about
Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis.A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit.Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature.Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit.Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.Update on the safety of linezolid.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Role of linezolid in the treatment of orthopedic infections.Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists.Update on linezolid: the first oxazolidinone antibiotic.Role of linezolid in the treatment of complicated skin and soft tissue infections.Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.Linezolid: effectiveness and safety for approved and off-label indications.Update on the appropriate use of linezolid in clinical practiceLinezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
P2860
Q24542412-9864F8D8-C607-40EF-8EF9-BEE7330C1B75Q33370027-BE0F23E2-D292-40B2-9EF3-3FCD5C8348F8Q33398776-DC7271D3-788F-4507-8D1C-600EDA3DBBCCQ33400056-FBBD1335-5FC3-4853-83A6-EDAD7237E73AQ33410244-737D4DE3-706C-4186-BF01-F1172AD5057CQ33412500-5FCA2770-0689-458D-A42D-5E29F2FD6391Q34489730-A88E57E1-47AF-44D5-B914-C3CF375C9386Q34987632-A1220563-D904-4227-9718-8C0E9F8B5A9BQ36083208-ED0A70E3-C802-429B-AF70-C47B3115ED9CQ36162348-50041365-782C-454A-B33A-E1D5A25381E4Q36188333-A4F1827B-C5AD-45EC-9635-DAA577ADBBFFQ36283744-82DE2AB4-200D-4027-BA73-6238A6BC4907Q36505478-5E1A9898-0206-4521-BC22-A022AD7A5CF8Q36735202-C01B1D18-7D9D-4B9A-81E2-5122A99A24C0Q36967288-C5FDC08F-6A87-4FCD-85D8-6847C686617AQ37116859-512FDF86-4F3C-44D1-A084-AB645E72103DQ46728767-C3BFA86C-BF29-459E-87DA-3942E2A58C56
P2860
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Linezolid does not increase th ...... linezolid and vancomycin use.
@ast
Linezolid does not increase th ...... linezolid and vancomycin use.
@en
type
label
Linezolid does not increase th ...... linezolid and vancomycin use.
@ast
Linezolid does not increase th ...... linezolid and vancomycin use.
@en
prefLabel
Linezolid does not increase th ...... linezolid and vancomycin use.
@ast
Linezolid does not increase th ...... linezolid and vancomycin use.
@en
P2093
P2860
P356
P1476
Linezolid does not increase th ...... linezolid and vancomycin use.
@en
P2093
Andrew F Shorr
David J Kuter
Naomi O'Grady
Stanley A Nasraway
Sue K Cammarata
P2860
P304
P356
10.1086/379327
P407
P577
2003-11-20T00:00:00Z